-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Initiates Coverage On Immutep with Market Outperform Rating, Announces Price Target of $6

Benzinga·02/17/2026 14:10:34
Listen to the news
Citizens analyst Reni J. Benjamin initiates coverage on Immutep (NASDAQ:IMMP) with a Market Outperform rating and announces Price Target of $6.